Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


02.08.2021

1 AJR Am J Roentgenol
1 Am J Pathol
1 Am J Respir Crit Care Med
2 Ann Surg Oncol
3 Ann Thorac Surg
2 Anticancer Res
1 BMC Cancer
2 Cancer Lett
1 Carcinogenesis
2 Chest
2 Clin Cancer Res
3 Clin Lung Cancer
1 Eur Respir J
1 Int J Cancer
8 Int J Radiat Oncol Biol Phys
4 J Cancer Res Clin Oncol
1 J Comput Assist Tomogr
1 J Nucl Med
1 J Thorac Cardiovasc Surg
6 J Thorac Oncol
3 JAMA Oncol
2 Lancet
7 Lung Cancer
1 Lung Cancer (Auckl)
6 Oncogene
3 Oncol Rep
1 PLoS Biol
1 PLoS Comput Biol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. NAGANO H, Takumi K, Nakajo M, Fukukura Y, et al
    Dual-Energy CT-Derived Electron Density for Diagnosing Metastatic Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: Comparison With Conventional CT and FDG PET/CT Findings.
    AJR Am J Roentgenol. 2021 Jul 28. doi: 10.2214/AJR.21.26208.
    PubMed         Abstract available


    Am J Pathol

  2. GOERTZEN N, Pappesch R, Fassunke J, Bruning T, et al
    Quantum Cascade Laser-Based Infrared Imaging as a Label-Free and Automated Approach to Determine Mutations in Lung Adenocarcinoma.
    Am J Pathol. 2021;191:1269-1280.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  3. GESTHALTER Y, Kathuria H, Moazed F
    Smoking Cessation and Cancer.
    Am J Respir Crit Care Med. 2021;203:P24-P25.
    PubMed        


    Ann Surg Oncol

  4. ZHAO ZR, Long H
    ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4551-4552.
    PubMed        

  5. WANG C, Wang S, Li Z, He W, et al
    A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Jul 28. pii: 10.1245/s10434-021-10504.
    PubMed         Abstract available


    Ann Thorac Surg

  6. AKPOVIRORO O, Asokan S, Steiling K, Rebello A, et al
    Lung Cancer Risk in Suspicious Lung Nodules With Negative Positron Emission Tomography Scan.
    Ann Thorac Surg. 2021 Jul 20. pii: S0003-4975(21)01261.
    PubMed         Abstract available

  7. MAYNE NR, Elser H, Lin BK, Raman V, et al
    The Impact of Extended Delayed Surgery for Indolent Lung Cancer or Part-solid Ground Glass Nodules.
    Ann Thorac Surg. 2021 Jul 27. pii: S0003-4975(21)01284.
    PubMed         Abstract available

  8. MAYNE NR, Potter A, Bharol K, Darling AJ, et al
    Perioperative Outcomes and Survival after Preoperative Immunotherapy for Non-small-cell Lung Cancer.
    Ann Thorac Surg. 2021 Jul 24. pii: S0003-4975(21)01282.
    PubMed         Abstract available


    Anticancer Res

  9. YAMANAKA M, Hayashi M, Yamada S, Sonohara F, et al
    A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes.
    Anticancer Res. 2021;41:3933-3940.
    PubMed         Abstract available

  10. OTSUKA T, Ueda K, Furukawa T, Koriyama C, et al
    Significance of Mitochondrial DNA Haplogroup on Epidermal Growth Factor Receptor Mutation in Japanese Patients With Lung Adenocarcinoma.
    Anticancer Res. 2021;41:3997-4004.
    PubMed         Abstract available


    BMC Cancer

  11. WU CE, Chang CF, Huang CY, Yang CT, et al
    Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
    BMC Cancer. 2021;21:859.
    PubMed         Abstract available


    Cancer Lett

  12. LIN S, Li Y, Wang D, Huang C, et al
    Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression.
    Cancer Lett. 2021;518:230-242.
    PubMed         Abstract available

  13. JIN M, Li G, Liu W, Wu X, et al
    Cigarette smoking induces aberrant N(6)-methyladenosine of DAPK2 to promote non-small cell lung cancer progression by activating NF-kappaB pathway.
    Cancer Lett. 2021;518:214-229.
    PubMed         Abstract available


    Carcinogenesis

  14. WANG Y, Ji M, Zhu M, Fan J, et al
    Genome-wide gene-smoking interaction study identified novel susceptibility loci for non-small cell lung cancer in Chinese populations.
    Carcinogenesis. 2021 Jul 23. pii: 6326566. doi: 10.1093.
    PubMed         Abstract available


    Chest

  15. FEDEWA SA, Bandi P, Smith RA, Silvestri GA, et al
    Lung Cancer Screening Rates During the COVID-19 Pandemic.
    Chest. 2021 Jul 20. pii: S0012-3692(21)01364-7. doi: 10.1016/j.chest.2021.
    PubMed        

  16. TANDJAOUI-LAMBIOTTE Y, Akrour Y, Gibelin A, Gonzalez F, et al
    Tyrosine kinase inhibitors for acute respiratory failure due to non-small-cell lung cancer involvement in intensive care unit.
    Chest. 2021 Jul 21. pii: S0012-3692(21)01358-1. doi: 10.1016/j.chest.2021.
    PubMed        


    Clin Cancer Res

  17. NAKAGAWA K, Nadal E, Garon EB, Nishio M, et al
    RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-small Cell Lung Cancer.
    Clin Cancer Res. 2021 Jul 22. pii: 1078-0432.CCR-21-0273.
    PubMed         Abstract available

  18. KOCH AL, Vellanki PJ, Drezner N, Li X, et al
    FDA Approval Summary: Osimertinib for adjuvant treatment of surgically resected non-small cell lung cancer, a collaborative Project Orbis review.
    Clin Cancer Res. 2021 Jul 22. pii: 1078-0432.CCR-21-1034.
    PubMed         Abstract available


    Clin Lung Cancer

  19. KOOPMAN B, Groen HJM, Schuuring E, Hiltermann TJN, et al
    Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature.
    Clin Lung Cancer. 2021 Jul 3. pii: S1525-7304(21)00178.
    PubMed         Abstract available

  20. JACOBS CD, Mehta K, Gao J, Wang X, et al
    Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2021 Jun 24. pii: S1525-7304(21)00159.
    PubMed         Abstract available

  21. SOCINSKI MA, Ozguroglu M, Villegas A, Daniel D, et al
    Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC).
    Clin Lung Cancer. 2021 Jun 12. pii: S1525-7304(21)00144.
    PubMed         Abstract available


    Eur Respir J

  22. LI G, Zhang X, Liu Y, Zhang J, et al
    Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study.
    Eur Respir J. 2021 Jul 29. pii: 13993003.01399-2021.
    PubMed         Abstract available


    Int J Cancer

  23. LAUTZ TB, Farooqui Z, Jenkins T, Heaton TE, et al
    Thoracoscopy vs thoracotomy for the management of metastatic osteosarcoma: A Pediatric Surgical Oncology Research Collaborative Study.
    Int J Cancer. 2021;148:1164-1171.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  24. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
    Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
    PubMed         Abstract available

  25. MCFARLANE MR, Hochstedler KA, Laucis AM, Sun Y, et al
    Predictors of Pneumonitis after Conventionally Fractionated Radiotherapy for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jul 24. pii: S0360-3016(21)02561.
    PubMed         Abstract available

  26. XU T, Meng QH, Gilchrist SC, Lin SH, et al
    Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiotherapy-Induced Cardiotoxicity in Non-Small Cell Lung Cancer Patients: A Secondary Analysis of a Prospective Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021 Jul 21. pii: S0360-3016(21)00905.
    PubMed         Abstract available

  27. HASLETT K, Bayman N, Franks K, Groom N, et al
    Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1341-1348.
    PubMed         Abstract available

  28. PAN T, Lu Y, Thomas MA, Liao Z, et al
    New Data-Driven Gated PET/CT Free of Misregistration Artifacts.
    Int J Radiat Oncol Biol Phys. 2021;109:1638-1646.
    PubMed         Abstract available

  29. TROVO M, Relevant A, Polesel J, Muraro E, et al
    Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1368-1376.
    PubMed         Abstract available

  30. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    PubMed         Abstract available

  31. THOR M, Apte A, Haq R, Iyer A, et al
    Using Auto-Segmentation to Reduce Contouring and Dose Inconsistency in Clinical Trials: The Simulated Impact on RTOG 0617.
    Int J Radiat Oncol Biol Phys. 2021;109:1619-1626.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  32. SU Z, Jiang Y, Li C, Zhong R, et al
    Relationship between lung function and lung cancer risk: a pooled analysis of cohorts plus Mendelian randomization study.
    J Cancer Res Clin Oncol. 2021 Jul 27. pii: 10.1007/s00432-021-03619.
    PubMed         Abstract available

  33. YANG Z, Yu R, Deng W, Wang W, et al
    Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer.
    J Cancer Res Clin Oncol. 2021 Jul 29. pii: 10.1007/s00432-021-03740.
    PubMed         Abstract available

  34. LI P, Hou F, Wang S, Luo N, et al
    A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H.
    J Cancer Res Clin Oncol. 2021;147:2483-2486.
    PubMed        

  35. OTA T, Kirita K, Matsuzawa R, Udagawa H, et al
    Correction to: Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
    J Cancer Res Clin Oncol. 2021 Jul 23. pii: 10.1007/s00432-021-03737.
    PubMed        


    J Comput Assist Tomogr

  36. HU X, Gu Q, Zhang K, Deng D, et al
    Dual-Energy Computed Tomography for the Diagnosis of Mediastinal Lymph Node Metastasis in Lung Cancer Patients: A Preliminary Study.
    J Comput Assist Tomogr. 2021;45:490-494.
    PubMed         Abstract available


    J Nucl Med

  37. ZHOU X, Jiang J, Yang X, Liu T, et al
    First-in-human evaluation of a PD-L1-binding peptide radiotracer in non-small cell lung cancer patients with PET.
    J Nucl Med. 2021 Jul 29. pii: jnumed.121.262045. doi: 10.2967/jnumed.121.262045.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  38. SIENICKI E, Onaitis M
    Commentary: New players in epidermal growth factor receptor tyrosine kinase inhibitor resistance.
    J Thorac Cardiovasc Surg. 2021;162:474-475.
    PubMed        


    J Thorac Oncol

  39. DZIADZIUSZKO R, Mok T, Peters S, Han JY, et al
    Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic Non-Small Cell Lung Cancer: Initial Results of the Phase 2 ALK-Positive Cohort.
    J Thorac Oncol. 2021 Jul 23. pii: S1556-0864(21)02321.
    PubMed         Abstract available

  40. PATEL SA, Herynk MH, Cascone T, Saigal B, et al
    Estrogen promotes resistance to bevacizumab in murine models of non-small cell lung cancer.
    J Thorac Oncol. 2021 Jul 23. pii: S1556-0864(21)02320.
    PubMed         Abstract available

  41. AREDO JV, Wakelee HA, Han SS
    A Moving Target: Integration of Smoking Cessation Into Screening for Second Primary Lung Cancer.
    J Thorac Oncol. 2021;16:e59-e60.
    PubMed        

  42. PELOSI G, Pasini F
    Over-Time Risk of Lung Cancer Is Largely Owing to Continuing Smoking Exposition: A Good Reason to Quit.
    J Thorac Oncol. 2021;16:e57-e59.
    PubMed        

  43. SINGH N, Agrawal S, Jiwnani S, Khosla D, et al
    Lung Cancer in India.
    J Thorac Oncol. 2021;16:1250-1266.
    PubMed        

  44. SOCINSKI MA, Nishio M, Jotte RM, Cappuzzo F, et al
    IMpower150 final overall survival analyses for atezolizumab plus bevacizumab and chemotherapy in first-line metastatic nonsquamous non-small cell lung cancer.
    J Thorac Oncol. 2021 Jul 23. pii: S1556-0864(21)02322.
    PubMed         Abstract available


    JAMA Oncol

  45. TSAKIRIDIS T, Pond GR, Wright J, Ellis PM, et al
    Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical Trial.
    JAMA Oncol. 2021 Jul 29. pii: 2782110. doi: 10.1001/jamaoncol.2021.2328.
    PubMed         Abstract available

  46. EZE C, Belka C, Manapov F
    Forging a Path for Metformin Use in Inoperable Locally Advanced Non-Small Cell Lung Cancer.
    JAMA Oncol. 2021 Jul 29. pii: 2782115. doi: 10.1001/jamaoncol.2021.2316.
    PubMed        

  47. SKINNER H, Hu C, Tsakiridis T, Santana-Davila R, et al
    Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial.
    JAMA Oncol. 2021 Jul 29. pii: 2782111. doi: 10.1001/jamaoncol.2021.2318.
    PubMed         Abstract available


    Lancet

  48. BAAS P, Scherpereel A, Nowak AK, Oukessou A, et al
    Heterogeneity of treatment effects in malignant pleural mesothelioma - Authors' reply.
    Lancet. 2021;398:302.
    PubMed        

  49. DI MAIO M, Tagliamento M
    Heterogeneity of treatment effects in malignant pleural mesothelioma.
    Lancet. 2021;398:301-302.
    PubMed        


    Lung Cancer

  50. SHEN Y, Zhang Y, Guo Y, Li W, et al
    Prognosis of lung cancer associated with cystic airspaces: A propensity score matching analysis.
    Lung Cancer. 2021;159:111-116.
    PubMed         Abstract available

  51. KOZONO DE, Stinchcombe TE, Salama JK, Bogart J, et al
    Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer.
    Lung Cancer. 2021;159:56-65.
    PubMed         Abstract available

  52. KOCHER F, Tymoszuk P, Amann A, Sprung S, et al
    Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition.
    Lung Cancer. 2021;159:84-95.
    PubMed         Abstract available

  53. RAD HS, Rad HS, Shiravand Y, Radfar P, et al
    The Pandora's box of novel technologies that may revolutionize lung cancer.
    Lung Cancer. 2021;159:34-41.
    PubMed         Abstract available

  54. ZHAO M, Wu J, Deng J, Wang T, et al
    Proposal for Rib invasion as an independent T descriptor for non-small cell lung cancer: A propensity-score matching analysis.
    Lung Cancer. 2021;159:27-33.
    PubMed         Abstract available

  55. USUZAKI T, Takahashi K, Umemiya K, Ishikuro M, et al
    Augmentation method for convolutional neural network that improves prediction performance in the task of classifying primary lung cancer and lung metastasis using CT images.
    Lung Cancer. 2021 Jul 16. pii: S0169-5002(21)00468.
    PubMed        

  56. VAN BREESCHOTEN J, Ismail R, Smit H, Schuurbiers O, et al
    An invisible group of COVID-19 victims; impact on Dutch lung cancer care.
    Lung Cancer. 2021 Jul 19. pii: S0169-5002(21)00476.
    PubMed        


    Lung Cancer (Auckl)

  57. FUJINO T, Suda K, Mitsudomi T
    Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges.
    Lung Cancer (Auckl). 2021;12:35-50.
    PubMed         Abstract available


    Oncogene

  58. MENG C, Zhan J, Chen D, Shao G, et al
    The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2.
    Oncogene. 2021;40:1706-1720.
    PubMed         Abstract available

  59. LIU PI, Chang AC, Lai JL, Lin TH, et al
    Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases.
    Oncogene. 2021;40:1503-1515.
    PubMed         Abstract available

  60. CHENG FJ, Chen CH, Tsai WC, Wang BW, et al
    Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC.
    Oncogene. 2021;40:1162-1175.
    PubMed         Abstract available

  61. LIU X, Wang F, Xu C, Chen X, et al
    Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.
    Oncogene. 2021;40:821-832.
    PubMed         Abstract available

  62. LIN WH, Chang YW, Hong MX, Hsu TC, et al
    STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
    Oncogene. 2021;40:791-805.
    PubMed         Abstract available

  63. GUHA P, Gardell J, Rabinowitz B, Lopes M, et al
    Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific.
    Oncogene. 2021;40:693-704.
    PubMed         Abstract available


    Oncol Rep

  64. ZHANG Y, Yao H, Li Y, Yang L, et al
    Circular RNA TADA2A promotes proliferation and migration via modulating of miR638/KIAA0101 signal in nonsmall cell lung cancer.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

  65. CHANG CY, Wu KL, Chang YY, Tsai PH, et al
    Amine oxidase, copper containing 3 exerts antimesenchymal transformation and enhances CD4(+) Tcell recruitment to prolong survival in lung cancer.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

  66. XU L, Qu JL, Song N, Zhang LY, et al
    Biological and clinical significance of flap endonuclease1 in triplenegative breast cancer: Support of metastasis and a poor prognosis.
    Oncol Rep. 2020 Oct 16. doi: 10.3892/or.2020.7812.
    PubMed         Abstract available


    PLoS Biol

  67. BIAYNA J, Garcia-Cao I, Alvarez MM, Salvadores M, et al
    Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells.
    PLoS Biol. 2021;19:e3001176.
    PubMed         Abstract available


    PLoS Comput Biol

  68. LIN YE, Shnitzer T, Talmon R, Villarroel-Espindola F, et al
    Graph of graphs analysis for multiplexed data with application to imaging mass cytometry.
    PLoS Comput Biol. 2021;17:e1008741.
    PubMed         Abstract available


    PLoS One

  69. STIEB DM, Berjawi R, Emode M, Zheng C, et al
    Systematic review and meta-analysis of cohort studies of long term outdoor nitrogen dioxide exposure and mortality.
    PLoS One. 2021;16:e0246451.
    PubMed         Abstract available


  70. Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
    PLoS One. 2021;16:e0255429.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: